Colgate-Palmolive Q2 Review: Profit Drops 17%, Brokerages Turn Bearish, Cut Target Price

Advertisement
Read Time: 2 mins
Brokerages bearish on the company. (Photo: Microsoft Copilot Generated Image)
Quick Read
Summary is AI-generated, newsroom-reviewed
  • Colgate-Palmolive India’s net profit fell 17% YoY to Rs 327.50 crore in Q2
  • Revenue declined 6.2% YoY to Rs 1,519.50 crore in the quarter ended September
  • EBITDA dropped 6% with margins contracting slightly to 30.6%
Did our AI summary help?
Let us know.

Colgate-Palmolive (India) Ltd. reported a 17% year-on-year decline in net profit to Rs 327.50 crore for the quarter ended September. Revenue dropped 6.2% to Rs 1,519.50 crore, while Ebitda fell 6% with margins contracting slightly to 30.6%. Following the subdued performance, brokerages including Citi, Investec, and Jefferies revised their target prices, with mixed outlooks on the company's near-term growth prospects.

Colgate Palmolive Q2 Highlights (YoY)

  • Revenue down 6.2% to Rs 1,519.50 crore versus Rs 1,619.11 crore.

  • Net Profit down 17% to Rs 327.50 crore versus Rs 395.05 crore.

  • Ebitda down 6% to Rs 465.43 crore versus Rs 497.35 crore.

  • Margin at 30.6% versus 30.7%

Notably, Colgate announced first interim dividend of Rs 24 per equity share for the fiscal 2026. The company announced distribution of nearly Rs 652.8 crore to shareholders.

Advertisement

Citi On Colgate

  • Maintain Sell and cut target price to Rs 2,100 from Rs 2,175

  • Weak Q2 -Tough Operating Environment, GST-Led Disruption

  • Expect gradually improving growth trajectory near-term

  • LUP structure is likely to offer near-term boost to volumes

  • Remain cautious on its sustained impact for HPC categories

  • Consumer behavior may shift towards reduced purchase frequency rather than heightened consumption

  • 41 times 1-year forward consensus P/E, the risk-reward is unfavourable.

Investec On Colgate

  • Maintain Sell and cut target price to Rs 2,279 from Rs 2,366

  • Subdued performance

  • Revenue falls on GST impact, high base

  • EBITDA margin stays under pressure on operating deleverage

  • Overall weakness in performs drives further EPS cuts

Jefferies On Colgate

  • Maintain Buy with target price of Rs 2,700

  • Expectedly Weak Quarter

  • Management blamed transitory issues related to GST rate cut

  • This resulted in destocking across the value chain, along with a high base

  • Premium portfolio, however, performed well, per mgmt.

  • Cut EPS by 4-5% - the stock will stay rangebound until there is a growth pickup

Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.

Loading...